Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt
The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for t...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Lilljequist, Lars Lindkvist, Maria Nordberg, Peter Pettersson, Ursula Sebhatu, Tesfai |
description | The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07459463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07459463</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074594633</originalsourceid><addsrcrecordid>eNqNjL0KwjAURrs4iPoOGRV6QdtadS6Kk5ObiNya1AbyU3IjNE4-uhHF2enwwfnOMHlWLpBHpaQRrLFOE7MNy9IcuNTCt0HBGqZZWv52LcwjKNTS2BkcoA3c2T58VKklx4c9LdIM8My64CSPYSjhiq62fXxxwbSgGPCCESo_TgYNKhKTL0cJ222P1R7u1EXHeLrcHL4xXxXLTVHm-R_KC9sXSNA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt</title><source>USPTO Issued Patents</source><creator>Lilljequist, Lars ; Lindkvist, Maria ; Nordberg, Peter ; Pettersson, Ursula ; Sebhatu, Tesfai</creator><creatorcontrib>Lilljequist, Lars ; Lindkvist, Maria ; Nordberg, Peter ; Pettersson, Ursula ; Sebhatu, Tesfai ; AstraZeneca AB</creatorcontrib><description>The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7459463$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7459463$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lilljequist, Lars</creatorcontrib><creatorcontrib>Lindkvist, Maria</creatorcontrib><creatorcontrib>Nordberg, Peter</creatorcontrib><creatorcontrib>Pettersson, Ursula</creatorcontrib><creatorcontrib>Sebhatu, Tesfai</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><title>Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt</title><description>The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjL0KwjAURrs4iPoOGRV6QdtadS6Kk5ObiNya1AbyU3IjNE4-uhHF2enwwfnOMHlWLpBHpaQRrLFOE7MNy9IcuNTCt0HBGqZZWv52LcwjKNTS2BkcoA3c2T58VKklx4c9LdIM8My64CSPYSjhiq62fXxxwbSgGPCCESo_TgYNKhKTL0cJ222P1R7u1EXHeLrcHL4xXxXLTVHm-R_KC9sXSNA</recordid><startdate>20081202</startdate><enddate>20081202</enddate><creator>Lilljequist, Lars</creator><creator>Lindkvist, Maria</creator><creator>Nordberg, Peter</creator><creator>Pettersson, Ursula</creator><creator>Sebhatu, Tesfai</creator><scope>EFH</scope></search><sort><creationdate>20081202</creationdate><title>Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt</title><author>Lilljequist, Lars ; Lindkvist, Maria ; Nordberg, Peter ; Pettersson, Ursula ; Sebhatu, Tesfai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074594633</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Lilljequist, Lars</creatorcontrib><creatorcontrib>Lindkvist, Maria</creatorcontrib><creatorcontrib>Nordberg, Peter</creatorcontrib><creatorcontrib>Pettersson, Ursula</creatorcontrib><creatorcontrib>Sebhatu, Tesfai</creatorcontrib><creatorcontrib>AstraZeneca AB</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lilljequist, Lars</au><au>Lindkvist, Maria</au><au>Nordberg, Peter</au><au>Pettersson, Ursula</au><au>Sebhatu, Tesfai</au><aucorp>AstraZeneca AB</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt</title><date>2008-12-02</date><risdate>2008</risdate><abstract>The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2,6 -dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt and to mixture thereof. Further, the present invention also relates to processes for obtaining them, the use of said compounds for the treatment of gastrointestinal disorders, and pharmaceutical compositions containing them.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07459463 |
source | USPTO Issued Patents |
title | Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A25%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lilljequist,%20Lars&rft.aucorp=AstraZeneca%20AB&rft.date=2008-12-02&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07459463%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |